Showing 8891-8900 of 21420 results for "".
Individualizing Management Strategies for PSVT: Incorporating Patient Preference
https://reachmd.com/programs/cme/individualizing-management-strategies-for-psvt-incorporating-patient-preference/68795/Are you optimally managing your patients with PSVT? Our experts offer best practices and guideline recommendations to improve outcomes in the real world.Detecting & Treating Arthralgia in IBD: What the Gastroenterologist Needs to Know
https://reachmd.com/programs/gi-insights/detecting-treating-arthralgia-in-ibd-what-the-gastroenterologist-needs-to-know/13312/With 50 percent of IBD patients experiencing arthralgia, how can you determine if it’s inflammatory or noninflammatory and treat it appropriately?Placenta Accreta: Strategies to Improve Diagnosis and Management
https://reachmd.com/programs/clinicians-roundtable/placenta-accreta-strategies-improve-diagnosis-and-management/7421/Placenta accreta, also known as invasive placentation, is on the rise in US labor and delivery wards. It’s also potentially deadly, and healthcare professionals need to know how to detect it quickly and manage it safely. Joining Dr. Matt Birnholz at Omnia Education’s Women’s Health Annual Visit inPA's Report: Current International Relief Efforts in Haiti
https://reachmd.com/programs/clinicians-roundtable/pas-report-current-international-relief-efforts-in-haiti/5201/Medical professionals across the world have joined together to help treat the injured survivors of Haiti's devastating earthquake. Physician assistants are also part of this global effort. PA Eric Holden, a volunteer with NYC Medics didn't know what to expect when he arrived in Haiti. Holden and theReviewing the Role of JAK Inhibitors in Atopic Dermatitis
https://reachmd.com/programs/dermconsult/reviewing-the-role-of-jak-inhibitors-in-atopic-dermatitis/13460/The FDA recently approved two oral JAK-1 inhibitors for mild-to-severe atopic dermatitis. Here's what we need to know about these new options.Targeting Psoriasis at the Source: New Evidence for Interferon Receptor Therapies
https://reachmd.com/programs/dermconsult/psoriasis-interferon-receptor-therapy/39675/Insights on PsA Management
https://reachmd.com/programs/practical-dermatology/insights-on-psa-management/23665/With about one-third of psoriasis patients likely to develop joint disease, dermatologists must be prepared to comanage PsA symptoms.Insulin Resistance and the Risk of Ischemic Stroke
https://reachmd.com/programs/focus-on-neurology-and-psychiatry/insulin-resistance-and-the-risk-of-ischemic-stroke/6088/Hundreds of millions of people may have insulin resistance worldwide. What is the connection between insulin resistance and the risk of ischemic stroke? Dr. Tatjana Rundek, associate professor of neurology and director of the clinical translational research division in the department of neurology ofIlluminating AOX Serum from ZO Skin Health
https://reachmd.com/topics/skincare/illuminating-aox-serum-from-zo-skin-health/35200/Treating the 5th Vital Sign: Pain
https://reachmd.com/programs/clinicians-roundtable/treating-the-5th-vital-sign-pain/3778/In 1999 the Joint Commission on the Accreditation of Healthcare Organizations (JCAHO) declared pain the fifth vital sign. Chronic pain affects more people than diabetes, heart disease and cancer combined. Has there been any real improvement in identifying and treating pain since the JCAHO edict? J